Clinical Trials in New York State

Showing 17041-17060 of 17,167 trials

Treatment of Hallucinosis/Psychosis in Parkinson's Disease by an Investigational Drug

NCT00087542

The primary objective is to demonstrate that the investigational new drug, ACP-103, is well tolerated by, and will not worsen parkinsonism in, patients with Parkinson's disease and psychosis. The secondary objectives are to determine whether ACP-103 will ameliorate psychosis in patients with Parkinson's disease and whether ACP-103 is safe in Parkinson's disease patients taking multiple anti-parkinsonian medications.

HallucinationsPsychosesParkinson's Disease

ACADIA Pharmaceuticals Inc.60 participantsStarted Mar 2004

Fountain Valley, California, United States • Sunnyvale, California, United States • Danbury, Connecticut, United States +10 more locations

COMPLETEDPhase 381 miles

Prevention of Autogenous Vein Graft Failure in Coronary Artery Bypass Procedures

NCT00042081

The purpose of this study is to determine the efficacy of graft pretreatment with CGT003 (E2F Duplex Decoy), as compared to placebo, on the incidence of patients experiencing vein graft failure after coronary artery bypass surgery.

Coronary Artery Disease

Anesiva, Inc.3,000 participantsStarted Jul 2002

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Birmingham, Alabama, United States +151 more locations

Treatment of Hallucinosis/Psychosis in Parkinson's Disease by an Investigational Drug

Prevention of Autogenous Vein Graft Failure in Coronary Artery Bypass Procedures

Find Trials by Condition in New York State

Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Osteoarthritis Pain.

Xcellerated T CellsTM in Patients With Multiple Myeloma

Safety and Efficacy of Galantamine in Patients With Dementia With Lewy Bodies

The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Chronic Back Pain.

Inhaled Doxorubicin Plus IV Docetaxel and Cisplatin in Patients With Non-Small-Cell Lung Carcinoma (NSCLC)

Proleukin in Combination With Rituxan in Patients With Intermediate and High-Grade Non-Hodgkin's Lymphoma.

Effectiveness Study Comparing Treatment With Drug(s) or Adjunctive VNS Therapy for Pharmacoresistant Partial Seizures

Longitudinal Optic Neuritis Study (LONS)

Autologous Cultured Myoblasts (BioWhittaker) Transplanted Via Myocardial Injection

Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan

A Safety and Efficacy Study of Intravenous E5564 in Patients With Severe Sepsis

Phase I Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile Of Lenalidomide (Revlimid®, CC-5013) With Pemetrexed In Subjects With Advanced Non-Small Cell Lung Cancer

Trial of rPA-102 Vaccine in Healthy Adult Volunteers

Surgery for Vocal Cord Paralysis

Phase II Study of Single Agent OSI-7904L in Patients With Gastric or Gastroesophageal (GEJ) Cancer

Study of NS-9 in Patients With Liver Metastases

Pilot Study of High-Dose Capsaicin Patches to Treat Postherpetic Neuralgia Pain

Study to Demonstrate That Muscle Pattern Recognition (MPR) is an Effective Evaluation Tool for Musculoskeletal Neck or Back Pain